+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COVID-19: Diagnosis and Management - Part II

  • ID: 5367439
  • Book
  • June 2021
  • Bentham Science Publishers Ltd
The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings.

This book is divided into two parts (I and II). Part I provides comprehensive information about 1) History of Coronaviruses, 2) Epidemiology of COVID-19, 3) Clinical presentation of this viral disease and 4) COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1) the prevention and treatment methodology, 2) mortality and long-term complications, 3) COVID-19 vaccines and future perspectives.

Key Features:
  • Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students
  • Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19.
  • Six chapters in the first part which focus on clinical basics of COVID-19.
  • Six chapters in the second part which cover broader topics for practical infection control.
  • Multiple tables and figures which summarize and highlight important points.
  • Presents a summary of the current standards for the evaluation and diagnosis of COVID-19.
  • Features a detailed list of references, abbreviations, and symbols.
This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVDI-19 diagnosis and management as part of their clinical training or professional work.
Note: Product cover images may vary from those shown
Chapter 1 Prevention of COVID-19: Facts to Overcome the Myths
  • Introduction
  • Measures to Prevent the Spread, Associated Myths and Facts
  • Personal Protective Equipment (Ppe)
  • Head Covers
  • Face Shield
  • Mask
  • Goggles
  • Gloves
  • Shoe Covers
  • Gowns or Coveralls
  • Sanitization and Disinfection
  • Hand Hygiene
  • For Public
  • Prevention of COVID-19 Among Frontline Healthcare Workers
  • Cleaning of Vegetables-Fruits
  • Safe Handling of Currency and Paper Documents
  • Cough or Respiratory Etiquettes
  • Precautions to be Taken while Coughing/Sneezing or Any Physical Contact
  • Spitting or Littering in Public
  • Disinfection of Public Places
  • Disposal and Disinfection of Ppes
  • Water Treatment and Waste Management
  • Management of Water and Faecal Waste
  • Safety of Water Supplies
  • Social Measures
  • Physical Distancing
  • Quarantine and Isolation
  • Home Quarantine
  • Institutional Quarantine
  • Staff Guidelines
  • Utility Guidelines
  • Lockdown and Travel Restrictions
  • Zonal Classification of the Geography
  • Prophylaxis for COVID-19
  • Dietary Recommendations for the Prevention of COVID-19
  • General Measures
  • Medicinal Plant Measures/Procedures
  • Medical Prophylaxis for Healthcare Workers and Contacts of a Positive Patient
  • Regular Screening
  • Precautions for Travel
  • Conclusion
  • List of Abbreviations
  • Rajesh Kumar, Mangesh Pradeep Kulkarni, Sheetu Wadhwa and Soundappan Kathirvel
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
Chapter 2 Current Treatment Methods for Coronavirus Disease-19
  • Introduction
  • Overview of Various Treatment Strategies for COVID-19
  • Hydroxychloroquine
  • Hcq in Treatment of COVID-19
  • Remdesivir
  • Remdesivir in Treatment of COVID-19
  • Lopinavir/Ritonavir
  • Lopinavir/Ritonavir in Treatment of COVID-19
  • Favipiravir
  • Favipiravir in Treatment of COVID-19
  • Azithromycin (Az)
  • Az in COVID-19 Treatment
  • Arbidol
  • Arbidol in Treatment of COVID-19
  • Ribavirin
  • Ribavirin in COVID-19 Treatment
  • Teicoplanin
  • Teicoplanin in COVID-19 Treatment
  • Ivermectin
  • Ivermectin in Treatment of COVID-19
  • Nitazoxanide
  • Nitazoxanide in COVID-19 Treatment
  • Corticosteroids
  • Corticosteroids in the Treatment of COVID-19
  • Immuno Modulating Agents-Interferons (Ifn's)
  • Ifn's in Treatment of COVID-19
  • Monoclonal Antibody Therapy
  • 80R Immunoglobulin G1 (Igg1)
  • Cr3014
  • Monoclonal Antibody Therapy in COVID-19 Treatment
  • Tocilizumab
  • Sarilumab
  • Limitations and Suggestions Regarding Mab's
  • Triple Therapy
  • Miscellaneous Drugs
  • Herbal Drugs for COVID-19
  • Glycyrrhizin
  • Glycyrrhizin in COVID-19
  • Hesperetin
  • Baicalin
  • Scutellarin
  • Plasma Therapy
  • Plasma Therapy in the Treatment of COVID-19
  • Kuldeep Kumar, Sonal, Pankaj Bhatia, Dhandeep Singh, Amteshwar S. Jaggi And Nirmal Singh
  • Potential of Stem Cell Therapy in COVID-19
  • Bcg Vaccine
  • Various Regulatory Guidelines Given by Nih (National Institute Of Health) for Treatment of COVID-19
  • Conclusion
  • List of Abbreviations
  • Authors Contribution
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
Chapter 3 COVID-19 and Mortality
  • Introduction
  • Representing Mortality - Mortality Rate Vs. Case-Fatality Rate
  • Fallacies in Estimating Mortality Using Case-Fatality Rate
  • Reporting COVID-19-Related Deaths
  • Comparing Case-Fatality Rates of COVID-19 with Other Related
  • Viral Diseases
  • Comparing COVID-19 Case-Fatality Rates Among Various Nations
  • Causes of Death in COVID-19
  • Parameters Predicting Mortality in COVID-19
  • Clinical Parameters
  • Age
  • Gender
  • Symptoms
  • Complications
  • Comorbid Illness
  • Smoking
  • Secondary Infections
  • Laboratory Parameters
  • Conclusion
  • Abbreviations
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
Chapter 4 Long Term Complications of COVID-19
  • Introduction
  • Long Term Complications of COVID-19
  • Complications of COVID-19 in Various Diseases
  • Diabetes Mellitus (Dm)
  • Hematological Complications
  • Cardiovascular Diseases
  • Central Nervous System Complications
  • Viral Encephalitis
  • Infectious Toxic Encephalopathy and Cerebrovascular Disease
  • Chronic Kidney Disease (Ckd)
  • Rimesh Pal and Sanjay Kumar Bhadada
  • Ankita Sood, Bimlesh Kumar Indu Melkani, Archit Sood, Pankaj Prashar, Anamika Gautam
  • Kardam Joshi and Dhara Patel
  • Asthma and Respiratory Disorders
  • Rheumatoid Arthritis (Ra)
  • Conclusion
  • Abbreviations
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
Chapter 5 Vaccine Development
  • COVID-19: Vaccine Development
  • COVID-19 Vaccine Development: Modulating the Host Immune
  • System
  • Types of Vaccines and Their Characteristics
  • Live-Attenuated Virus and Inactivated Whole Virus Vaccines
  • Subunit Vaccines
  • Vaccines Based on Virus-Like Particles (Vlps)
  • Viral Vector-Based Vaccines
  • Dna Vaccines
  • Novel Approaches: Usage of Multidisciplinary Fields
  • Serum Albumin Strategy
  • Natural Product (Plant) Based Technology
  • Nanotechnology and Material Science
  • Mrna Based Approaches
  • Animal Models to Test the Immunogenic Potential of Candidate
  • Vaccine Antigens
  • Animal Models Currently in Practice
  • Humanized Mice Models
  • Novel Approach of Using Zebrafish (Their Advantages)
  • Current Status of Vaccine Development
  • Bench to Bedside: Obstacles and Outcomes
  • Lessons from Previous Vaccine Development
  • List of Abbreviations
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
Chapter 6 The Future of COVID-19 Treatment
  • Introduction
  • Drugs Affecting Viral Replication and Translation in COVID-19
  • Disease
  • Drugs Interfering with Inflammation and Overcoming Cytokine
  • Storm in COVID-19 Disease
  • Anticancer Drugs in the Treatment of COVID-19 Disease
  • Antiparasitic, Antiprotozoal, and Antifungal Drugs in the Treatment of COVID-19 Disease
  • Drugs Affecting the Renin-Angiotensin-Aldosterone System In
  • COVID-19
  • Priya Sha Rma, Shivani Joshi, Aishwarya Joshi, Nikunj Tandel and Rajeev K.
  • Tyagi
  • Sahil Arora, Manvendra Kumar, Gaurav Joshi and Raj Kumar
  • Miscellaneous
  • Discussion and Conclusion
  • Abbreviations
  • Consent for Publication
  • Conflict of Interest
  • Acknowledgements
  • References
  • Subject Index
Note: Product cover images may vary from those shown
  • Neeraj Mittal
  • Sanjay Kumar Bhadada
  • O. P. Katare
  • Varun Garg
Note: Product cover images may vary from those shown
Adroll
adroll